|
68 Companies |
|
79 Products |
|
79 Products |
|
71 Mechanisms of Action |
|
0 Trials |
|
484 News |
|
| «12345678910» |
- Trial primary completion date: Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis (clinicaltrials.gov) - May 6, 2016
P=N/A, N=10, Recruiting, Sponsor: Wake Forest University
Trial primary completion date: Dec 2015 --> Dec 2016
- triamcinolone acetonide topical / Generic mfg.
Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - May 6, 2016
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest University
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jun 2016 --> Oct 2016
- | MRX 6 / Akari Therap
Trial termination, Trial primary completion date: Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% (clinicaltrials.gov) - May 6, 2016
P2, N=73, Terminated, Sponsor: Celsus Therapeutics PLC
Trial primary completion date: Jun 2016 --> Oct 2016 Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Mar 2015; Interim analysis showed lack of efficacy
- |||| lebrikizumab (LY3650150) / Roche, Almirall, Eli Lilly
Trial completion: TREBLE: A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis (clinicaltrials.gov) - May 6, 2016
P2, N=212, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Mar 2015; Interim analysis showed lack of efficacy Recruiting --> Completed
- Enrollment status: Immune Reactions in Contact Dermatitis Affected Skin (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=500, Enrolling by invitation, Sponsor: Rockefeller University
Recruiting --> Completed Recruiting --> Enrolling by invitation
- Trial primary completion date: Assessing Risk of Food Insecurity Within Households of Children With Food Allergy (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=650, Enrolling by invitation, Sponsor: Arkansas Children's Hospital Research Institute
Recruiting --> Enrolling by invitation Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) - Apr 12, 2016
P=N/A, N=2600, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Mar 2016 --> Dec 2016
- Trial primary completion date, IO biomarker: Interferon Responses in Eczema Herpeticum (clinicaltrials.gov) - Apr 12, 2016
P=N/A, N=120, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Mar 2016 --> Dec 2016 Trial primary completion date: Mar 2016 --> Dec 2016
- Enrollment open, Trial initiation date, Trial primary completion date: Randomized Controlled Trial of an Eczema Care Plan (clinicaltrials.gov) - Apr 11, 2016
P=N/A, N=200, Recruiting, Sponsor: Children's Hospital Boston
Trial primary completion date: Mar 2016 --> Dec 2016 Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> Jun 2015 | Trial primary completion date: Sep 2015 --> Jun 2016
- tacrolimus topical / Generic mfg.
Trial completion, Adherence: Protopic Adherence and Efficacy in Korean Eczema Patient (clinicaltrials.gov) - Mar 30, 2016
P=N/A, N=50, Completed, Sponsor: Pusan National University Hospital
Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> Jun 2015 | Trial primary completion date: Sep 2015 --> Jun 2016 Recruiting --> Completed
- ||||||| Dupixent (dupilumab) / Sanofi, Regeneron
Trial completion, Monotherapy: SOLO 1: Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis (clinicaltrials.gov) - Mar 29, 2016
P3, N=674, Completed, Sponsor: Regeneron Pharmaceuticals
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Photocil (Topical) for the Treatment of Atopic Dermatitis (clinicaltrials.gov) - Mar 25, 2016
P=N/A, N=7, Completed, Sponsor: Applied Biology, Inc.
Active, not recruiting --> Completed Recruiting --> Completed | N=50 --> 7 | Trial primary completion date: Jul 2014 --> Dec 2014
- Enrollment change: The Effects of Probiotics in Atopic Dermatitis (clinicaltrials.gov) - Mar 16, 2016
P=N/A, N=0, Withdrawn, Sponsor: University of California, Los Angeles
Recruiting --> Completed | N=50 --> 7 | Trial primary completion date: Jul 2014 --> Dec 2014 N=56 --> 0
- Trial completion: Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients (clinicaltrials.gov) - Mar 16, 2016
P3, N=30, Completed, Sponsor: Mahidol University
N=56 --> 0 Active, not recruiting --> Completed
- Trial completion, Enrollment change: Cognitive Behavior Therapy for Atopic Dermatitis (clinicaltrials.gov) - Mar 5, 2016
P=N/A, N=9, Completed, Sponsor: Karolinska Institutet
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=25 --> 9
- |||| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Trial completion, Enrollment change: Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis (clinicaltrials.gov) - Feb 29, 2016
P2, N=306, Completed, Sponsor: MedImmune LLC
Active, not recruiting --> Completed | N=25 --> 9 Active, not recruiting --> Completed | N=184 --> 306
- || AIMab7195 / Nestle
Enrollment closed: Safety and Tolerability of XmAb (clinicaltrials.gov) - Feb 10, 2016
P1, N=72, Active, not recruiting, Sponsor: Xencor, Inc.
Active, not recruiting --> Completed | N=184 --> 306 Recruiting --> Active, not recruiting
- ||||| Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment change: CHRONOS: Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis (clinicaltrials.gov) - Jan 22, 2016
P3, N=739, Active, not recruiting, Sponsor: Regeneron Pharmaceuticals
Recruiting --> Active, not recruiting N=1478 --> 739
- Enrollment closed, Trial primary completion date: Bleach Bath Treatment of Adults With Atopic Dermatitis (clinicaltrials.gov) - Jan 19, 2016
P=N/A, N=40, Active, not recruiting, Sponsor: University of Rochester
N=1478 --> 739 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Apr 2016
- triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial primary completion date, IO biomarker, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Jan 17, 2016
P4, N=15, Recruiting, Sponsor: University of California, San Francisco
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Apr 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- Enrollment change: BAMBOO: Management of Eczema by Specific Probiotic Strains (clinicaltrials.gov) - Jan 16, 2016
P3, N=0, Withdrawn, Sponsor: Agentschap NL
Trial primary completion date: Jun 2015 --> Jun 2016 N=120 --> 0
- ||||| Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment change: CHRONOS: Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis (clinicaltrials.gov) - Jan 15, 2016
P3, N=1478, Active, not recruiting, Sponsor: Regeneron Pharmaceuticals
N=120 --> 0 N=739 --> 1478
- ||||||| Eucrisa (crisaborole) / Pfizer
Trial completion, Trial primary completion date: CORE 2: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis (clinicaltrials.gov) - Dec 30, 2015
P3, N=764, Completed, Sponsor: Anacor Pharmaceuticals, Inc.
N=739 --> 1478 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015
- ||||||| Eucrisa (crisaborole) / Pfizer
Trial completion, Trial primary completion date: CORE 1: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis (clinicaltrials.gov) - Dec 30, 2015
P3, N=763, Completed, Sponsor: Anacor Pharmaceuticals, Inc.
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015
- Enrollment open, Trial primary completion date, Head-to-Head: CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants (clinicaltrials.gov) - Dec 29, 2015
P=N/A, N=40, Recruiting, Sponsor: Northwestern University
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Dec 2017
- ||| Trial completion, Enrollment change, Trial primary completion date: Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents (clinicaltrials.gov) - Dec 21, 2015
P=N/A, N=126, Completed, Sponsor: University of Aarhus
Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Dec 2017 Active, not recruiting --> Completed | N=90 --> 126 | Trial primary completion date: Jul 2014 --> Sep 2015
- Trial primary completion date: Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis (clinicaltrials.gov) - Dec 18, 2015
P=N/A, N=40, Recruiting, Sponsor: Rutgers, The State University of New Jersey
Active, not recruiting --> Completed | N=90 --> 126 | Trial primary completion date: Jul 2014 --> Sep 2015 Trial primary completion date: Jun 2015 --> Jun 2016
- Trial primary completion date: Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis (clinicaltrials.gov) - Dec 12, 2015
P=N/A, N=10, Recruiting, Sponsor: Wake Forest University
Trial primary completion date: Jun 2015 --> Jun 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- triamcinolone acetonide topical / Generic mfg.
Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - Dec 12, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest University
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Jun 2015 --> Jun 2016
- Trial completion: PREVEX: A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema (clinicaltrials.gov) - Dec 5, 2015
P=N/A, N=770, Completed, Sponsor: University of Copenhagen
Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Completed
- |||| rosiptor (AQX-1125) / Neoleukin Therap
Trial completion: KINSHIP: Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis (clinicaltrials.gov) - Dec 4, 2015
P2, N=54, Completed, Sponsor: Aquinox Pharmaceuticals, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- |||| pegcantratinib (SNA-120) / Sienna
Trial completion: A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis (clinicaltrials.gov) - Nov 26, 2015
P2, N=188, Completed, Sponsor: Creabilis SA
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion, Trial primary completion date: The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis (clinicaltrials.gov) - Nov 19, 2015
P=N/A, N=24, Completed, Sponsor: Seoul National University Hospital
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Aug 2015 --> May 2015
- Trial primary completion date: Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) - Nov 16, 2015
P=N/A, N=2600, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed | Trial primary completion date: Aug 2015 --> May 2015 Trial primary completion date: Dec 2015 --> Mar 2016
- Trial primary completion date, IO biomarker: Interferon Responses in Eczema Herpeticum (clinicaltrials.gov) - Nov 15, 2015
P=N/A, N=120, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Dec 2015 --> Mar 2016
- Enrollment closed, Trial primary completion date: Cognitive Behavior Therapy for Atopic Dermatitis (clinicaltrials.gov) - Nov 6, 2015
P=N/A, N=25, Active, not recruiting, Sponsor: Karolinska Institutet
Trial primary completion date: Dec 2015 --> Mar 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015
- ||| Trial completion: COPES: Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® Regimen (clinicaltrials.gov) - Nov 6, 2015
P=N/A, N=58, Completed, Sponsor: Hyphens Pharma Pte Ltd
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015 Active, not recruiting --> Completed
- || lebrikizumab (LY3650150) / Roche, Almirall, Eli Lilly
Trial primary completion date: TREBLE: A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis (clinicaltrials.gov) - Nov 3, 2015
P2, N=200, Recruiting, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Trial primary completion date: Dec 2016 --> Apr 2016
- Furestem-AD (hUCB-MSCs) / Kangstem Biotech
Trial primary completion date: Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD) (clinicaltrials.gov) - Oct 29, 2015
P1/2, N=34, Completed, Sponsor: Kang Stem Biotech Co., Ltd.
Trial primary completion date: Dec 2016 --> Apr 2016 Trial primary completion date: Aug 2015 --> May 2015
- Enrollment change, Trial withdrawal: 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis (clinicaltrials.gov) - Oct 22, 2015
P1, N=0, Withdrawn, Sponsor: Makati Medical Center
Trial primary completion date: Aug 2015 --> May 2015 N=60 --> 0 | Recruiting --> Withdrawn
- Trial completion, Trial primary completion date: The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests (clinicaltrials.gov) - Oct 9, 2015
P=N/A, N=160, Completed, Sponsor: Meir Medical Center
N=60 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | Trial primary completion date: Oct 2012 --> Apr 2014
- Trial completion, Trial initiation date: The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel (clinicaltrials.gov) - Oct 8, 2015
P=N/A, N=120, Completed, Sponsor: Meir Medical Center
Recruiting --> Completed | Trial primary completion date: Oct 2012 --> Apr 2014 Not yet recruiting --> Completed | Initiation date: Nov 2012 --> Apr 2015
- | Trial completion: A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants (clinicaltrials.gov) - Oct 6, 2015
P0, N=46, Completed, Sponsor: Janssen Research & Development, LLC
Not yet recruiting --> Completed | Initiation date: Nov 2012 --> Apr 2015 Recruiting --> Completed
- ||| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Enrollment closed, Trial primary completion date: Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis (clinicaltrials.gov) - Sep 30, 2015
P2, N=184, Active, not recruiting, Sponsor: MedImmune LLC
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Nov 2015
- || Dupixent (dupilumab) / Sanofi, Regeneron
Trial primary completion date: Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis (clinicaltrials.gov) - Sep 25, 2015
P2, N=109, Completed, Sponsor: Regeneron Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Nov 2015 Trial primary completion date: Jul 2013 --> Mar 2013
- Trial completion, Trial primary completion date: Placebo Effect in the Treatment of Atopic Dermatitis (clinicaltrials.gov) - Sep 18, 2015
P=N/A, N=166, Completed, Sponsor: Margitta Worm
Trial primary completion date: Jul 2013 --> Mar 2013 Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Nov 2013
- ||| Trial completion, Enrollment change, Trial primary completion date: Probiotics and Allergic Diseases (clinicaltrials.gov) - Sep 3, 2015
P=N/A, N=240, Completed, Sponsor: GenMont Biotech Incorporation
Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Nov 2013 Recruiting --> Completed | N=360 --> 240 | Trial primary completion date: Jun 2013 --> Jun 2014
- | Furestem-AD (hUCB-MSCs) / Kangstem Biotech
Trial completion, Trial primary completion date: Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD) (clinicaltrials.gov) - Sep 2, 2015
P1/2, N=30, Completed, Sponsor: Kang Stem Biotech Co., Ltd.
Recruiting --> Completed | N=360 --> 240 | Trial primary completion date: Jun 2013 --> Jun 2014 Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Aug 2015
- Enrollment closed: Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients (clinicaltrials.gov) - Sep 1, 2015
P3, N=30, Active, not recruiting, Sponsor: Mahidol University
Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Aug 2015 Recruiting --> Active, not recruiting
- Trial primary completion date: Placebo Effect in the Treatment of Atopic Dermatitis (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=140, Recruiting, Sponsor: Margitta Worm
Recruiting --> Active, not recruiting Trial primary completion date: Oct 2014 --> Oct 2016